Product Images Succinylcholine Chloride
View Photos of Packaging, Labels & Appearance
- image-01-5ml-syringe - image 01 5ml syringe
- image-02-10ml-syringe - image 02 10ml syringe
- image-03-syringe-instructions - image 03 syringe instructions
- image-04-succinylcholine-structural-formula - image 04 succinylcholine structural formula
- image-05-container-label-5ml-pfs-ir - image 05 container label 5ml pfs ir
- image-06-container-label-10ml-pfs-ir - image 06 container label 10ml pfs ir
- image-07-mono-carton-label-5ml - image 07 mono carton label 5ml
- image-08-mono-carton-label-10ml - image 08 mono carton label 10ml
- image-09-outer-carton-label-5ml - image 09 outer carton label 5ml
- image-10-outer-carton-label-10ml - image 10 outer carton label 10ml
- image-11-sticker-label - image 11 sticker label
Product Label Images
The following 11 images provide visual information about the product associated with Succinylcholine Chloride NDC 43066-127 by Baxter Healthcare Corporation, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
image-05-container-label-5ml-pfs-ir - image 05 container label 5ml pfs ir

This text provides information about a medical product - a Chloride Injection with succinylcholine as an active ingredient. It is indicated for intravenous or intramuscular administration and contains a warning regarding its paralyzing effect, specifically causing respiratory arrest. The text emphasizes the importance of facilities being readily available for artificial respiration. The product is to be used with aseptic technique, and any unused portion should be discarded. The mention of specific codes and lot numbers indicates the importance of tracking and quality control.*
image-06-container-label-10ml-pfs-ir - image 06 container label 10ml pfs ir

This text is from the label of Chloride Injection, USP, a medication that contains a paralyzing agent. It warns about the potential side effects, such as respiratory arrest, and advises that facilities for artificial respiration must be readily available. The medication is intended for intravenous or intramuscular administration and comes in a 10 mL single-dose pre-filled syringe. The label instructs to discard any unused portion and use aseptic technique when administering. The manufacturer of this medication is identified as Baytr Healthoare Corporation, with the product being made in India.*
image-07-mono-carton-label-5ml - image 07 mono carton label 5ml

This is a warning label for a paralyzing agent medication used for intravenous or intramuscular administration. It is important to have facilities available for artificial respiration in case of respiratory arrest. The medication is a sterile, non-pyrogenic solution containing succinylcholine chloride, sodium chloride, and other ingredients. Users must adhere to aseptic technique, ensure solution clarity before use, and store the medication between 2 °C to 8 °C. Detailed dosage, precautions, and directions for use can be found in the package insert.*
image-08-mono-carton-label-10ml - image 08 mono carton label 10ml

This is a description of a pharmaceutical product called BT Chloride Injection, USP 200 mg/10 mL. It is a paralyzing agent that causes respiratory arrest and must only be used under the supervision of medical professionals. The solution is preservative-free and comes in a single-dose pre-filled syringe for intravenous or intramuscular administration. It is important to follow aseptic technique when using this product. The package insert provides information on dosage, precautions, indications, and directions for use. Storage instructions recommend keeping it in a refrigerator at 2°C to 8°C (36°F to 46°F).*
image-09-outer-carton-label-5ml - image 09 outer carton label 5ml

This text provides important information about a medication identified as Chloride Injection, USP, including warnings about its paralyzing properties and the need for immediate availability of facilities for artificial respiration. The medication is for intravenous or intramuscular administration and is preservative-free. It comes in a 5X5 mL single-dose pre-filled syringe and should be discarded if unused. The text also includes details about the manufacturer and instructions for storage.*
image-10-outer-carton-label-10ml - image 10 outer carton label 10ml

This is a description of Chloride Injection, USP, which is a paralyzing agent used for intravenous or intramuscular administration. The medication is sterile, non-pyrogenic, and preservative-free. Each mL contains succinylcholine chloride USP and sodium chloride USP. It is important to discard any unused portion and use aseptic technique. The packaging includes 5 x 10 mL single-dose pre-filled syringes. Detailed dosage, precautions, indications, and directions for use can be found in the package insert. The medication should be stored in the refrigerator between 2 °C to 8 °C. Facilities for artificial respiration must be immediately available due to its potential to cause respiratory arrest.*
image-11-sticker-label - image 11 sticker label

The text contains multiple warnings about a paralyzing agent that causes respiratory arrest and stresses the importance of having facilities available for artificial respiration. This indicates a hazardous substance that requires caution and preparedness for potential respiratory complications.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.